Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

5-Methoxy-7,N,N-trimethyltryptamine

From Wikipedia, the free encyclopedia
Chemical compound

Pharmaceutical compound
5-Methoxy-7,N,N-trimethyltryptamine
Identifiers
  • 2-(5-Methoxy-7-methyl-1H-indol-3-yl)-N,N-dimethylethanamine
CAS Number
PubChemCID
ChemSpider
UNII
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC14H20N2O
Molar mass232.327 g·mol−1
3D model (JSmol)
  • CC1=C(NC=C2CCN(C)C)C2=CC(OC)=C1
  • InChI=1S/C14H20N2O/c1-10-7-12(17-4)8-13-11(5-6-16(2)3)9-15-14(10)13/h7-9,15H,5-6H2,1-4H3 checkY
  • Key:YGAOMGVUIWNFMD-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

5-Methoxy-7,N,N-trimethyltryptamine (5-MeO-7,N,N-TMT,5-MeO-7-TMT), is atryptaminederivative which acts as apartial agonist at the5-HT2serotoninreceptors, with an EC50 of 63.9 nM and an efficacy of 66.2% at 5-HT2A (vs 5-HT), and weaker activity at 5-HT2B and 5-HT2C.[1][2][3] In animal tests, both7,N,N-TMT and 5-MeO-7,N,N-TMT produced behavioural responses similar to those of psychedelic drugs such asDMT and5-MeO-DMT, but compounds with larger 7-position substituents such as 7-ethyl-DMT and 7-bromo-DMT did not produce psychedelic-appropriate responding despite high 5-HT2 receptorbinding affinity, suggesting these may be antagonists or weak partial agonists for the 5-HT2 receptors.[4] The related compound 7-MeO-MiPT (cf.5-MeO-MiPT) was also found to be inactive, suggesting that the 7-position has poor tolerance for bulky groups at this position, at least if agonist activity is desired.[5]

See also

[edit]

References

[edit]
  1. ^Patentscope.Banister S, Jorgensen W, Jinlong T. Compounds. Patent WO 2023/115166. Retrieved 2025-05-12
  2. ^Benington F, Morin RD, Bradley RJ (1976)."7-(N,N-Trimethyl)-5-methoxytryptamine".Journal of Heterocyclic Chemistry.13 (4):749–751.doi:10.1002/jhet.5570130412.
  3. ^Lyon RA, Titeler M, Seggel MR, Glennon RA (January 1988). "Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens".European Journal of Pharmacology.145 (3):291–7.doi:10.1016/0014-2999(88)90432-3.PMID 3350047.
  4. ^Glennon RA, Schubert E, Jacyno JM, Rosecrans JA (November 1980). "Studies on several 7-substituted N,N-dimethyltryptamines".Journal of Medicinal Chemistry.23 (11):1222–6.doi:10.1021/jm00185a014.PMID 6779006.
  5. ^Repke DB, Grotjahn DB, Shulgin AT (July 1985). "Psychotomimetic N-methyl-N-isopropyltryptamines. Effects of variation of aromatic oxygen substituents".Journal of Medicinal Chemistry.28 (7):892–6.doi:10.1021/jm00145a007.PMID 4009612.
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Tryptamines
4-Hydroxytryptamines
andesters/ethers
5-Hydroxy- and
5-methoxytryptamines
N-Acetyltryptamines
α-Alkyltryptamines
Cyclized tryptamines
Isotryptamines
Related compounds


Stub icon

Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=5-Methoxy-7,N,N-trimethyltryptamine&oldid=1290146478"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp